TTC4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.663200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.465000E-01
Normal-vs-Stage2
3.891800E-01
Normal-vs-Stage3
1.600960E-01
Normal-vs-Stage4
8.049800E-01
Stage1-vs-Stage2
5.358800E-01
Stage1-vs-Stage3
2.661800E-01
Stage1-vs-Stage4
2.506100E-02
Stage2-vs-Stage3
7.818300E-02
Stage2-vs-Stage4
1.992830E-01
Stage3-vs-Stage4
5.806300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.871600E-01
Normal-vs-AfricanAmerican
6.999400E-01
Normal-vs-Asian
1.339960E-01
Caucasian-vs-AfricanAmerican
7.054400E-01
Caucasian-vs-Asian
3.480200E-01
AfricanAmerican-vs-Asian
3.691200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.679800E-01
Normal-vs-Female
4.881600E-01
Male-vs-Female
2.896600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.514000E-01
Normal-vs-Age(41-60Yrs)
7.039200E-01
Normal-vs-Age(61-80Yrs)
2.479200E-01
Normal-vs-Age(81-100Yrs)
2.915000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.067600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.830800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.165000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.857700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.774020E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.922400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.472800E-01
Normal-vs-Daily Drinker
3.516400E-01
Normal-vs-Weekly Drinker
5.205400E-01
Normal-vs-Occasional Drinker
7.380400E-01
Normal-vs-Social Drinker
4.396800E-01
Non Drinker-vs-Daily Drinker
5.814600E-01
Non Drinker-vs-Weekly Drinker
7.543800E-01
Non Drinker-vs-Occasional Drinker
1.522100E-02
Non Drinker-vs-Social Drinker
2.042800E-01
Daily Drinker-vs-Weekly Drinker
9.334400E-01
Daily Drinker-vs-Occasional Drinker
9.050200E-02
Daily Drinker-vs-Social Drinker
4.549400E-01
Weekly Drinker-vs-Occasional Drinker
2.856400E-01
Weekly Drinker-vs-Social Drinker
5.693800E-01
Occasional Drinker-vs-Social Drinker
3.282200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.850400E-01
Normal-vs-Grade 2
8.531400E-01
Normal-vs-Grade 3
8.571400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.650380E-02
Grade 1-vs-Grade 3
3.345900E-02
Grade 1-vs-Grade 4
7.850400E-01
Grade 2-vs-Grade 3
8.649000E-01
Grade 2-vs-Grade 4
8.531400E-01
Grade 3-vs-Grade 4
8.571400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.685400E-01
Normal-vs-NonDiabetic
3.534000E-01
Diabetic-vs-NonDiabetic
3.660400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.907000E-01
Normal-vs-NoPancreatitis
3.385200E-01
Pancreatitis-vs-NoPancreatitis
6.605200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.883600E-01
Normal-vs-N1
4.209800E-01
N0-vs-N1
6.019000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.147000E-01
Normal-vs-TP53-NonMutant
4.616200E-01
TP53-Mutant-vs-TP53-NonMutant
7.368100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
